{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:37:57Z","timestamp":1768279077547,"version":"3.49.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been classified into variants of interest (VOIs) or concern (VOCs) to prioritize global monitoring and research on variants with potential risks to public health. The SARS-CoV-2 high-rate mutation can directly impact the clinical disease progression, epidemiological behavior, immune evasion, vaccine efficacy, and transmission rates. Therefore, epidemiological surveillance is crucial for controlling the COVID-19 pandemic. In the present study, we aimed to describe the prevalence of wild-type (WT) SARS-CoV-2 and Delta and Omicron variants in Jalisco State, Mexico, from 2021 to 2022, and evaluate the possible association of these variants with clinical manifestations of COVID-19.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Four thousand and ninety-eight patients diagnosed with COVID-19 by real-time PCR (COVIFLU, Genes2Life, Mexico) from nasopharyngeal samples from January 2021 to January 2022 were included. Variant identification was performed by the RT-qPCR Master Mut Kit (Genes2Life, Mexico). A study population follow-up was performed to identify patients who had experienced reinfection after being vaccinated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and Discussion<\/jats:title><jats:p>Samples were grouped into variants according to the identified mutations: 46.3% were Omicron, 27.9% were Delta, and 25.8% were WT. The proportions of dry cough, fatigue, headache, muscle pain, conjunctivitis, fast breathing, diarrhea, anosmia, and dysgeusia were significantly different among the abovementioned groups (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001). Anosmia and dysgeusia were mainly found in WT-infected patients, while rhinorrhea and sore throat were more prevalent in patients infected with the Omicron variant. For the reinfection follow-up, 836 patients answered, from which 85 cases of reinfection were identified (9.6%); Omicron was the VOC that caused all reported reinfection cases. In this study, we demonstrate that the Omicron variant caused the biggest outbreak in Jalisco during the pandemic from late December 2021 to mid-February 2022 but with a less severe form than the one demonstrated by Delta and WT. The co-analysis of mutations and clinical outcomes is a public health strategy with the potential to infer mutations or variants that could increase disease severity and even be an indicator of long-term sequelae of COVID-19.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1149795","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T14:51:14Z","timestamp":1682607074000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico"],"prefix":"10.3389","volume":"11","author":[{"given":"Marcela","family":"Pe\u00f1a Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Hern\u00e1ndez Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natali","family":"Vega Maga\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Viera Segura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariel","family":"Garc\u00eda Chagoll\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazael Ramiro","family":"Ceja G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas Carlos","family":"Mora Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Israel","family":"Renter\u00eda Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Octavio Patricio","family":"Garc\u00eda Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Francisco","family":"Mu\u00f1oz Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12985-020-01363-5","article-title":"The newly emerged COVID-19 disease: a systemic review","volume":"17","author":"Abebe","year":"2020","journal-title":"Virol J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.coviro.2012.07.005","article-title":"Implications of altered replication fidelity on the evolution and pathogenesis of coronaviruses","volume":"2","author":"Smith","year":"2012","journal-title":"Curr Opin Virol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/prot.26042","article-title":"Human SARS-CoV-2 spike protein mutations","volume":"89","author":"Guruprasad","year":"2021","journal-title":"Proteins Struct Funct Bioinf"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/v14030640","article-title":"Mutations and evolution of the SARS-CoV-2 spike protein","volume":"14","author":"Magazine","year":"2022","journal-title":"Viruses"},{"key":"ref6","unstructured":"2022"},{"key":"ref7","unstructured":"2022"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"8540","DOI":"10.1038\/s41598-022-12479-9","article-title":"Assessment of mutations on RBD in the spike protein of SARS-CoV-2 alpha, Delta and Omicron variants","volume":"12","author":"da Costa","year":"2022","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1101\/2022.05.25.493484","article-title":"Molecular investigations of selected spike protein mutations in SARS-CoV-2: Delta and Omicron variants and Omicron sub variants","author":"Roy","year":"2022","journal-title":"bioRxiv"},{"key":"ref10","unstructured":""},{"key":"ref11","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1038\/s41467-022-32665-7","article-title":"Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat Commun"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41392-021-00852-5","article-title":"SARS-CoV-2 omicron strain exhibits potent capabilities for immune evasion and viral entrance","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1101\/2022.01.29.478316","article-title":"Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies","author":"Giron","year":"2022","journal-title":"bioRxiv"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3390\/v14061139","article-title":"Differential pathogenesis of SARS-CoV-2 variants of concern in human ACE2-expressing mice","volume":"14","author":"Natekar","year":"2022","journal-title":"Viruses"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"eabn8057","DOI":"10.1126\/scitranslmed.abn8057","article-title":"Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection","volume":"14","author":"Evans","year":"2022","journal-title":"Sci Transl Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.16.472934","article-title":"Neutralization and stability of SARS-CoV-2 Omicron variant","author":"Zeng","year":"2021","journal-title":"bioRxiv"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"000684","DOI":"10.1099\/mgen.0.000684","article-title":"Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms","volume":"7","author":"Barona-G\u00f3mez","year":"","journal-title":"Microbiol Soc"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"868414","DOI":"10.3389\/fcimb.2022.868414","article-title":"SARS-CoV-2 mutations and COVID-19 clinical outcome: mutation global frequency dynamics and structural modulation hold the key","volume":"12","author":"Maurya","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrmicro.2016.182","article-title":"Clinical and biological insights from viral genome sequencing","volume":"15","author":"Houldcroft","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.3390\/ijms23063143","article-title":"An upgrade on the surveillance system of SARS-CoV-2: deployment of new methods for genetic inspection","volume":"23","author":"Mu\u00f1oz-Valle","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"672562","DOI":"10.3389\/fcimb.2021.672562","article-title":"RT-qPCR assays for rapid detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 mutations: a screening strategy to identify variants with clinical impact","volume":"11","author":"Vega-Maga\u00f1a","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"735658","DOI":"10.3389\/fpubh.2021.735658","article-title":"A local health situation room for COVID-19: recommendations for decision-making from a higher education institution in Mexico","volume":"9","author":"Ramos Herrera","year":"2021","journal-title":"Front Public Health"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"10644","DOI":"10.3390\/ijerph182010644","article-title":"A comprehensive descriptive epidemiological and clinical analysis of SARS-CoV-2 in West-Mexico during COVID-19 pandemic 2020","volume":"18","author":"Viera-Segura","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/v14040653","article-title":"SARS-CoV-2: evolution and emergence of new viral variants","volume":"14","author":"Flores-Vega","year":"2022","journal-title":"Viruses"},{"key":"ref25","unstructured":""},{"key":"ref26","unstructured":""},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3390\/v13112161","article-title":"Genetic analysis of SARS-CoV-2 variants in Mexico during the first year of the COVID-19 pandemic","volume":"13","author":"Taboada","year":"2021","journal-title":"Viruses"},{"key":"ref28","unstructured":"2021"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/v14061165","article-title":"Dominance of three sublineages of the SARS-CoV-2 Delta variant in Mexico","volume":"14","author":"Taboada","year":"2022","journal-title":"Viruses"},{"key":"ref30","unstructured":"2022"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"o7","DOI":"10.1136\/bmj.o7","article-title":"Omicron: South Africa says fourth wave peak has passed as it lifts curfew","volume":"376","author":"Mahase","year":"2022","journal-title":"BMJ"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"815389","DOI":"10.3389\/fmed.2022.815389","article-title":"SARS-CoV-2 mutations and their impact on diagnostics, therapeutics and vaccines","volume":"9","author":"Thakur","year":"2022","journal-title":"Front Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3390\/v14050919","article-title":"SARS-CoV-2 omicron variant, lineage BA.1, is associated with lower viral load in nasopharyngeal samples compared to Delta variant","volume":"14","author":"Sentis","year":"2022","journal-title":"Viruses"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e29165","DOI":"10.1097\/MD.0000000000029165","article-title":"Omicron SARS-CoV-2 variant of concern: a review on its transmissibility, immune evasion, reinfection, and severity","volume":"101","author":"Mohsin","year":"2022","journal-title":"Medicine"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"877101","DOI":"10.3389\/fimmu.2022.877101","article-title":"SARS-CoV-2 omicron variant: epidemiological features, biological characteristics, and clinical significance","volume":"13","author":"Guo","year":"2022","journal-title":"Front Immunol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e69091","DOI":"10.7554\/eLife.69091","article-title":"N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2","volume":"10","author":"Tian","year":"2021","journal-title":"elife"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"846996","DOI":"10.3389\/fmolb.2022.846996","article-title":"Decreased interfacial dynamics caused by the N501Y mutation in the SARS-CoV-2 S1 spike:ACE2 complex","volume":"9","author":"Ahmed","year":"2022","journal-title":"Front Mol Biosci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41586-021-04245-0","article-title":"The N501Y spike substitution enhances SARS-CoV-2 infection and transmission","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","article-title":"SARS-CoV-2 omicron variant: recent progress and future perspectives","volume":"7","author":"Fan","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"111903","DOI":"10.1016\/j.celrep.2022.111903","article-title":"A delicate balance between antibody evasion and ACE2 affinity for omicron BA.2.75","volume":"42","author":"Huo","year":"2023","journal-title":"Cell Rep"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.csbj.2023.02.019","article-title":"Reversal of the unique Q493R mutation increases the affinity of omicron S1-RBD for ACE2","volume":"21","author":"Philip","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e1009629","DOI":"10.1371\/journal.pcbi.1009629","article-title":"Modeling the onset of symptoms of COVID-19: effects of SARS-CoV-2 variant","volume":"17","author":"Larsen","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"100114","DOI":"10.1016\/j.medidd.2021.100114","article-title":"The Delta variant mutations in the receptor binding domain of SARS-CoV-2 show enhanced electrostatic interactions with the ACE2","volume":"13","author":"Goher","year":"2022","journal-title":"Med Drug Discov"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3390\/clinpract11040093","article-title":"Analysis of the Delta variant B.1.617.2 COVID-19","volume":"11","author":"Shiehzadegan","year":"2021","journal-title":"Clin Pract"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"n3103","DOI":"10.1136\/bmj.n3103","article-title":"Covid-19: runny nose, headache, and fatigue are commonest symptoms of omicron, early data show","volume":"375","author":"Iacobucci","year":"2021","journal-title":"BMJ"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41577-022-00681-9","article-title":"Omicron entry route","volume":"22","author":"Pia","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID study","volume":"399","author":"Menni","year":"2022","journal-title":"Lancet"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e133-e141","DOI":"10.1101\/2022.01.18.22269082","article-title":"Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom","volume":"76","author":"Vihta","year":"2022","journal-title":"Clin Infect Dis"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"e069503","DOI":"10.1136\/bmj-2021-069503","article-title":"Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves","volume":"378","author":"Tan","year":"2022","journal-title":"BMJ"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"151","DOI":"10.24875\/RIC.20000207","article-title":"Impact of comorbidities in Mexican SARS-CoV-2-positive patients: a retrospective analysis in a National Cohort","volume":"72","author":"Kammar-Garc\u00eda","year":"2020","journal-title":"Rev Invest Cl\u00edn"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"o1431","DOI":"10.1136\/bmj.o1431","article-title":"Comorbidities and Covid-19","volume":"377","author":"Adab","year":"2022","journal-title":"BMJ"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00705-022-05365-2","article-title":"The ins and outs of SARS-CoV-2 variants of concern (VOCs)","volume":"167","author":"Salehi-Vaziri","year":"2022","journal-title":"Arch Virol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"eabn4947","DOI":"10.1126\/science.abn4947","article-title":"Increased risk of SARS-CoV-2 reinfection associated with emergence of omicron in South Africa","volume":"376","author":"Pulliam","year":"2022","journal-title":"Science"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","article-title":"Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic","volume":"398","author":"Karim","year":"2021","journal-title":"Lancet Lond Engl"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1149795\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T14:51:17Z","timestamp":1682607077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1149795\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":55,"alternative-id":["10.3389\/fpubh.2023.1149795"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1149795","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,27]]},"article-number":"1149795"}}